# Efficacy and Safety of Imatinib in Scleroderma

> **NCT00479934** · PHASE2 · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 28 (actual)

## Conditions studied

- Scleroderma, Localized
- Scleroderma, Systemic

## Interventions

- **DRUG:** imatinib mesylate

## Key facts

- **NCT ID:** NCT00479934
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-12
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-05-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00479934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00479934, "Efficacy and Safety of Imatinib in Scleroderma". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00479934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*